HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Fayad, R. Articles by Qiao, L. Search for Related Content PubMed PubMed Citation Articles by Fayad, R. Articles by Qiao, L. Pubmed/NCBI databases Substance via MeSH Medline Plus Health Information Genes and Gene Therapy Immunization Seniors' Health

Oral Administration with Papillomavirus Pseudovirus Encoding IL-2 Fully Restores Mucosal and Systemic Immune Responses to Vaccinations in Aged Mice¹

Department of Microbiology and Immunology, Stritch School of Medicine, Loyola University Medical Center, Maywood, IL

Infectious diseases are one of the major threats for the elderly because their immune system is often compromised, and vaccinations to prevent these infections are not effective. A major defect in their immune system seems to be the inability of T cells to produce IL-2. We used papillomavirus (PV) pseudoviruses (PSVs) as a model vaccine and a gene delivery vector to address how to enhance immune responses to vaccinations. We found that oral immunization with PV PSV induced minimal mucosal and systemic Abs and CTLs specific for the PSVs in aged mice compared with young adult mice. In addition, fewer specific Th cells were generated in the aged mice. When aged mice were immunized with PV PSVs encoding human IL-2, specific Th cells were generated, producing murine IL-2, IL-4, and IFN-. Further, specific Abs and CTLs were induced, resulting in protection against mucosal viral challenge. Thus, this study provided a basis for clinical trials using PV PSVs encoding IL-2 for vaccination of the elderly.

This article has been cited by other articles:

				L. Bousarghin, A. Touze, G. Gaud, S. Iochmann, E. Alvarez, P. Reverdiau, J. Gaitan, M.-L. Jourdan, P.-Y. Sizaret, and P. L. Coursaget Inhibition of cervical cancer cell growth by human papillomavirus virus-like particles packaged with human papillomavirus oncoprotein short hairpin RNAs Mol. Cancer Ther., February 1, 2009; 8(2): 357 - 365. [Abstract] [Full Text] [PDF]

				B. Ferko, C. Kittel, J. Romanova, S. Sereinig, H. Katinger, and A. Egorov Live Attenuated Influenza Virus Expressing Human Interleukin-2 Reveals Increased Immunogenic Potential in Young and Aged Hosts J. Virol., December 1, 2006; 80(23): 11621 - 11627. [Abstract] [Full Text] [PDF]

				M. L. Janas, P. Groves, N. Kienzle, and A. Kelso IL-2 Regulates Perforin and Granzyme Gene Expression in CD8+ T Cells Independently of Its Effects on Survival and Proliferation J. Immunol., December 15, 2005; 175(12): 8003 - 8010. [Abstract] [Full Text] [PDF]

				Y. Huang, R. Fayad, A. Smock, A. M. Ullrich, and L. Qiao Induction of Mucosal and Systemic Immune Responses against Human Carcinoembryonic Antigen by an Oral Vaccine Cancer Res., August 1, 2005; 65(15): 6990 - 6999. [Abstract] [Full Text] [PDF]